GlobeNewswire Inc.··NaInstil Bio Extends Runway Past 2027 Amid Strategic Pipeline Overhaul
$TIL reports $74.7M cash position funding ops beyond 2027. R&D spending drops 87% YoY as company pursues acquisitions and in-licensing deals.
TILfinancial resultscash position